Effect of lipopolysaccharide on uterine contractions and prostaglandin production in pregnant rats

Toshiaki Okawa, Hiroshi Suzuki, Kaoru Yaanagida, Akira Sato, Yuri Vedernikov, George Saade, Robert Garfield

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

OBJECTIVE: Our aim was to evaluate the effect of lipopolysaccharide on prostaglandin production and on contraction of isolated myometrial strips from preterm pregnant rats. STUDY DESIGN: Pregnant Wistar rats on day 17 of gestation were killed 3 hours after intraperitoneal injection of lipopolysaccharide (1.5 mg/kg) or vehicle, with or without pretreatment with indomethacin (5 mg/kg administered intraperitoneally) 1 hour beforehand. Concentrations of endotoxin in maternal serum and amniotic fluid, prostaglandin F and prostaglandin E 2 in amniotic fluid, and progesterone in maternal serum were determined. Longitudinal uterine strips were prepared, placed in organ chambers with Krebs-Ringer solution, aerated with 95% oxygen and 5% carbon dioxide (37°C, pH ∼7.4), and equilibrated at 1g passive tension. Concentration-contraction relationships to oxytocin were determined. Samples of bathing solution were collected 10 minutes after the concentration of oxytocin was maximal. Prostaglandins and progesterone were measured by radioimmunoassay and endotoxin was measured by the Endospecy (Seikagaku Kogyo, Tokyo, Japan) kit. RESULTS: Lipopolysaccharide treatment significantly increased the levels of prostaglandin F and prostaglandin E 2 in amniotic fluid. Treatment with lipopolysaccharide inhibited the production and release of prostaglandin F and prostaglandin E 2 that were activated by oxytocin in uterine strips and increased the sensitivity of strips to the contractile effect of oxytocin. Indomethacin did not affect the basal or the lipopolysaccharide-activated levels of endotoxin in serum and amniotic fluid and exerted a counteraction on lipopolysaccharide-induced increases in concentrations of prostaglandin F and prostaglandin E 2 in amniotic fluid. Indomethacin counteracted oxytocin-activated production and release of prostaglandin F and prostaglandin E 2 in uterine tissues after lipopolysaccharide administration without changing the sensitivity of uterine strips to oxytocin. Concentrations of progesterone were not changed after lipopolysaccharide, indomethacin, or their combined application, which suggests that the changes described were not associated with alterations in the levels of the hormone. CONCLUSIONS: The activation of the uterine contractile system by prostaglandin and oxytocin during intraamniotic infection may be one of the causes of preterm delivery. A combination of an oxytocin receptor antagonist and an inhibitor of cyclooxygenase may be beneficial in prevention or treatment of preterm labor.

Original languageEnglish (US)
Pages (from-to)84-89
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume184
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Uterine Contraction
Oxytocin
Prostaglandins
Lipopolysaccharides
Prostaglandins F
Amniotic Fluid
Prostaglandins E
Indomethacin
Endotoxins
Progesterone
Serum
Mothers
Oxytocin Receptors
Cyclooxygenase Inhibitors
Tokyo
Premature Obstetric Labor
Intraperitoneal Injections
Carbon Dioxide
Radioimmunoassay
Wistar Rats

Keywords

  • Lipopolysaccharide
  • Oxytocin
  • Preterm labor
  • Prostaglandins
  • Uterine contractility

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Effect of lipopolysaccharide on uterine contractions and prostaglandin production in pregnant rats. / Okawa, Toshiaki; Suzuki, Hiroshi; Yaanagida, Kaoru; Sato, Akira; Vedernikov, Yuri; Saade, George; Garfield, Robert.

In: American Journal of Obstetrics and Gynecology, Vol. 184, No. 2, 2001, p. 84-89.

Research output: Contribution to journalArticle

Okawa, Toshiaki ; Suzuki, Hiroshi ; Yaanagida, Kaoru ; Sato, Akira ; Vedernikov, Yuri ; Saade, George ; Garfield, Robert. / Effect of lipopolysaccharide on uterine contractions and prostaglandin production in pregnant rats. In: American Journal of Obstetrics and Gynecology. 2001 ; Vol. 184, No. 2. pp. 84-89.
@article{f8683ea744cc463a82cb1a3c50eb7773,
title = "Effect of lipopolysaccharide on uterine contractions and prostaglandin production in pregnant rats",
abstract = "OBJECTIVE: Our aim was to evaluate the effect of lipopolysaccharide on prostaglandin production and on contraction of isolated myometrial strips from preterm pregnant rats. STUDY DESIGN: Pregnant Wistar rats on day 17 of gestation were killed 3 hours after intraperitoneal injection of lipopolysaccharide (1.5 mg/kg) or vehicle, with or without pretreatment with indomethacin (5 mg/kg administered intraperitoneally) 1 hour beforehand. Concentrations of endotoxin in maternal serum and amniotic fluid, prostaglandin F 2α and prostaglandin E 2 in amniotic fluid, and progesterone in maternal serum were determined. Longitudinal uterine strips were prepared, placed in organ chambers with Krebs-Ringer solution, aerated with 95{\%} oxygen and 5{\%} carbon dioxide (37°C, pH ∼7.4), and equilibrated at 1g passive tension. Concentration-contraction relationships to oxytocin were determined. Samples of bathing solution were collected 10 minutes after the concentration of oxytocin was maximal. Prostaglandins and progesterone were measured by radioimmunoassay and endotoxin was measured by the Endospecy (Seikagaku Kogyo, Tokyo, Japan) kit. RESULTS: Lipopolysaccharide treatment significantly increased the levels of prostaglandin F 2α and prostaglandin E 2 in amniotic fluid. Treatment with lipopolysaccharide inhibited the production and release of prostaglandin F 2α and prostaglandin E 2 that were activated by oxytocin in uterine strips and increased the sensitivity of strips to the contractile effect of oxytocin. Indomethacin did not affect the basal or the lipopolysaccharide-activated levels of endotoxin in serum and amniotic fluid and exerted a counteraction on lipopolysaccharide-induced increases in concentrations of prostaglandin F 2α and prostaglandin E 2 in amniotic fluid. Indomethacin counteracted oxytocin-activated production and release of prostaglandin F 2α and prostaglandin E 2 in uterine tissues after lipopolysaccharide administration without changing the sensitivity of uterine strips to oxytocin. Concentrations of progesterone were not changed after lipopolysaccharide, indomethacin, or their combined application, which suggests that the changes described were not associated with alterations in the levels of the hormone. CONCLUSIONS: The activation of the uterine contractile system by prostaglandin and oxytocin during intraamniotic infection may be one of the causes of preterm delivery. A combination of an oxytocin receptor antagonist and an inhibitor of cyclooxygenase may be beneficial in prevention or treatment of preterm labor.",
keywords = "Lipopolysaccharide, Oxytocin, Preterm labor, Prostaglandins, Uterine contractility",
author = "Toshiaki Okawa and Hiroshi Suzuki and Kaoru Yaanagida and Akira Sato and Yuri Vedernikov and George Saade and Robert Garfield",
year = "2001",
doi = "10.1067/mob.2001.108083",
language = "English (US)",
volume = "184",
pages = "84--89",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Effect of lipopolysaccharide on uterine contractions and prostaglandin production in pregnant rats

AU - Okawa, Toshiaki

AU - Suzuki, Hiroshi

AU - Yaanagida, Kaoru

AU - Sato, Akira

AU - Vedernikov, Yuri

AU - Saade, George

AU - Garfield, Robert

PY - 2001

Y1 - 2001

N2 - OBJECTIVE: Our aim was to evaluate the effect of lipopolysaccharide on prostaglandin production and on contraction of isolated myometrial strips from preterm pregnant rats. STUDY DESIGN: Pregnant Wistar rats on day 17 of gestation were killed 3 hours after intraperitoneal injection of lipopolysaccharide (1.5 mg/kg) or vehicle, with or without pretreatment with indomethacin (5 mg/kg administered intraperitoneally) 1 hour beforehand. Concentrations of endotoxin in maternal serum and amniotic fluid, prostaglandin F 2α and prostaglandin E 2 in amniotic fluid, and progesterone in maternal serum were determined. Longitudinal uterine strips were prepared, placed in organ chambers with Krebs-Ringer solution, aerated with 95% oxygen and 5% carbon dioxide (37°C, pH ∼7.4), and equilibrated at 1g passive tension. Concentration-contraction relationships to oxytocin were determined. Samples of bathing solution were collected 10 minutes after the concentration of oxytocin was maximal. Prostaglandins and progesterone were measured by radioimmunoassay and endotoxin was measured by the Endospecy (Seikagaku Kogyo, Tokyo, Japan) kit. RESULTS: Lipopolysaccharide treatment significantly increased the levels of prostaglandin F 2α and prostaglandin E 2 in amniotic fluid. Treatment with lipopolysaccharide inhibited the production and release of prostaglandin F 2α and prostaglandin E 2 that were activated by oxytocin in uterine strips and increased the sensitivity of strips to the contractile effect of oxytocin. Indomethacin did not affect the basal or the lipopolysaccharide-activated levels of endotoxin in serum and amniotic fluid and exerted a counteraction on lipopolysaccharide-induced increases in concentrations of prostaglandin F 2α and prostaglandin E 2 in amniotic fluid. Indomethacin counteracted oxytocin-activated production and release of prostaglandin F 2α and prostaglandin E 2 in uterine tissues after lipopolysaccharide administration without changing the sensitivity of uterine strips to oxytocin. Concentrations of progesterone were not changed after lipopolysaccharide, indomethacin, or their combined application, which suggests that the changes described were not associated with alterations in the levels of the hormone. CONCLUSIONS: The activation of the uterine contractile system by prostaglandin and oxytocin during intraamniotic infection may be one of the causes of preterm delivery. A combination of an oxytocin receptor antagonist and an inhibitor of cyclooxygenase may be beneficial in prevention or treatment of preterm labor.

AB - OBJECTIVE: Our aim was to evaluate the effect of lipopolysaccharide on prostaglandin production and on contraction of isolated myometrial strips from preterm pregnant rats. STUDY DESIGN: Pregnant Wistar rats on day 17 of gestation were killed 3 hours after intraperitoneal injection of lipopolysaccharide (1.5 mg/kg) or vehicle, with or without pretreatment with indomethacin (5 mg/kg administered intraperitoneally) 1 hour beforehand. Concentrations of endotoxin in maternal serum and amniotic fluid, prostaglandin F 2α and prostaglandin E 2 in amniotic fluid, and progesterone in maternal serum were determined. Longitudinal uterine strips were prepared, placed in organ chambers with Krebs-Ringer solution, aerated with 95% oxygen and 5% carbon dioxide (37°C, pH ∼7.4), and equilibrated at 1g passive tension. Concentration-contraction relationships to oxytocin were determined. Samples of bathing solution were collected 10 minutes after the concentration of oxytocin was maximal. Prostaglandins and progesterone were measured by radioimmunoassay and endotoxin was measured by the Endospecy (Seikagaku Kogyo, Tokyo, Japan) kit. RESULTS: Lipopolysaccharide treatment significantly increased the levels of prostaglandin F 2α and prostaglandin E 2 in amniotic fluid. Treatment with lipopolysaccharide inhibited the production and release of prostaglandin F 2α and prostaglandin E 2 that were activated by oxytocin in uterine strips and increased the sensitivity of strips to the contractile effect of oxytocin. Indomethacin did not affect the basal or the lipopolysaccharide-activated levels of endotoxin in serum and amniotic fluid and exerted a counteraction on lipopolysaccharide-induced increases in concentrations of prostaglandin F 2α and prostaglandin E 2 in amniotic fluid. Indomethacin counteracted oxytocin-activated production and release of prostaglandin F 2α and prostaglandin E 2 in uterine tissues after lipopolysaccharide administration without changing the sensitivity of uterine strips to oxytocin. Concentrations of progesterone were not changed after lipopolysaccharide, indomethacin, or their combined application, which suggests that the changes described were not associated with alterations in the levels of the hormone. CONCLUSIONS: The activation of the uterine contractile system by prostaglandin and oxytocin during intraamniotic infection may be one of the causes of preterm delivery. A combination of an oxytocin receptor antagonist and an inhibitor of cyclooxygenase may be beneficial in prevention or treatment of preterm labor.

KW - Lipopolysaccharide

KW - Oxytocin

KW - Preterm labor

KW - Prostaglandins

KW - Uterine contractility

UR - http://www.scopus.com/inward/record.url?scp=0035128573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035128573&partnerID=8YFLogxK

U2 - 10.1067/mob.2001.108083

DO - 10.1067/mob.2001.108083

M3 - Article

VL - 184

SP - 84

EP - 89

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2

ER -